Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer

9Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The association between the microsomal epoxide hydrolase 1 gene (EPHX1) Tyr113His polymorphism and lung cancer and breast cancer risk has been reported in many recent studies, but there is no consensus among the results. Thus, we examined the association between the EPHX1 Tyr113His polymorphism and lung cancer through a meta-analysis. A comprehensive literature search was performed using the Pubmed and Embase databases. Odds ratios with 95% confidence intervals were used to assess the strength of associations. Our meta-analysis suggested that the Tyr113His polymorphism was associated with lung cancer risk in Asians under 3 genetic models, including a C vs T, CC vs TT, and recessive model. However, the risk was decreased in Caucasians under the genetic models, including a C vs T, CC vs TT, or CT vs TT, dominant, and recessive model. In contrast, there was no association with breast cancer risk for any of the genetic models. Our meta-analysis suggested that the EPHX1 Tyr113His polymorphism may be a risk factor for lung cancer in Asians, whereas it may be a decreased risk factor among Caucasians. However, this polymorphism was not found to be associated with breast cancer.

Cite

CITATION STYLE

APA

Tan, X., Wang, Y. Y., Chen, X. Y., Xian, L., Guo, J. J., Liang, G. B., & Chen, M. W. (2014). Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer. Genetics and Molecular Research, 13(3), 7437–7446. https://doi.org/10.4238/2014.September.12.10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free